Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
- PMID: 36069569
- PMCID: PMC10151059
- DOI: 10.1002/hep.32777
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
Abstract
Background and aims: Detailed investigation of the biological pathways leading to hepatic fibrosis and identification of liver fibrosis biomarkers may facilitate early interventions for pediatric cholestasis.
Approach and results: A targeted enzyme-linked immunosorbent assay-based panel of nine biomarkers (lysyl oxidase, tissue inhibitor matrix metalloproteinase (MMP) 1, connective tissue growth factor [CTGF], IL-8, endoglin, periostin, Mac-2-binding protein, MMP-3, and MMP-7) was examined in children with biliary atresia (BA; n = 187), alpha-1 antitrypsin deficiency (A1AT; n = 78), and Alagille syndrome (ALGS; n = 65) and correlated with liver stiffness (LSM) and biochemical measures of liver disease. Median age and LSM were 9 years and 9.5 kPa. After adjusting for covariates, there were positive correlations among LSM and endoglin ( p = 0.04) and IL-8 ( p < 0.001) and MMP-7 ( p < 0.001) in participants with BA. The best prediction model for LSM in BA using clinical and lab measurements had an R2 = 0.437; adding IL-8 and MMP-7 improved R2 to 0.523 and 0.526 (both p < 0.0001). In participants with A1AT, CTGF and LSM were negatively correlated ( p = 0.004); adding CTGF to an LSM prediction model improved R2 from 0.524 to 0.577 ( p = 0.0033). Biomarkers did not correlate with LSM in ALGS. A significant number of biomarker/lab correlations were found in participants with BA but not those with A1AT or ALGS.
Conclusions: Endoglin, IL-8, and MMP-7 significantly correlate with increased LSM in children with BA, whereas CTGF inversely correlates with LSM in participants with A1AT; these biomarkers appear to enhance prediction of LSM beyond clinical tests. Future disease-specific investigations of change in these biomarkers over time and as predictors of clinical outcomes will be important.
Copyright © 2023 American Association for the Study of Liver Diseases.
Figures




References
-
- Song Z, Dong R, Fan Y, Zheng S. Identification of Serum Protein Biomarkers in Biliary Atresia by Mass Spectrometry and ELISA. J Pediatr Gastroenterol Nutr. - PubMed
-
- Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, et al. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res;156:229–234. - PubMed
-
- Pereira TN, Lewindon PJ, Smith JL, Murphy TL, Lincoln DJ, Shepherd RW, Ramm GA. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease. J Hepatol 2004;41:576–583. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK062481/DK/NIDDK NIH HHS/United States
- U01 DK062470/DK/NIDDK NIH HHS/United States
- UL1 TR001857/TR/NCATS NIH HHS/United States
- U01 DK062436/DK/NIDDK NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- U01 DK062466/DK/NIDDK NIH HHS/United States
- U01 DK084575/DK/NIDDK NIH HHS/United States
- UL1 TR001855/TR/NCATS NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- U01 DK103149/DK/NIDDK NIH HHS/United States
- UL1 TR000130/TR/NCATS NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- U01 DK084585/DK/NIDDK NIH HHS/United States
- U01 DK103140/DK/NIDDK NIH HHS/United States
- UL1 TR001872/TR/NCATS NIH HHS/United States
- UL1 TR001878/TR/NCATS NIH HHS/United States
- U01 DK084538/DK/NIDDK NIH HHS/United States
- U01 DK062453/DK/NIDDK NIH HHS/United States
- UL1 TR002535/TR/NCATS NIH HHS/United States
- U01 DK103135/DK/NIDDK NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- UL1 RR025014/RR/NCRR NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- U01 DK084536/DK/NIDDK NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- U01 DK062456/DK/NIDDK NIH HHS/United States
- U01 DK062445/DK/NIDDK NIH HHS/United States
- K08 HS026510/HS/AHRQ HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- U24 DK062456/DK/NIDDK NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 DK062500/DK/NIDDK NIH HHS/United States
- U01 DK062497/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous